Loading insider details...
Beta
Latest Form 4 (Nov 4, 2025): Grant/Award of 250,000 MRKR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 4, 2025 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 250,000 | n/a |
| Feb 14, 2025 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 50,000 | n/a |
| Jun 7, 2024 | Allovir, Inc. (ALVR) | Grant/Award | 35,000 | n/a |
| May 12, 2023 | Allovir, Inc. (ALVR) | Grant/Award | 35,000 | n/a |
| May 11, 2023 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 100,000 | n/a |
| Mar 1, 2023 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 46,487 | n/a |
| May 19, 2022 | Allovir, Inc. (ALVR) | Grant/Award | 27,500 | n/a |
| Mar 29, 2022 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 140,823 | n/a |
| Feb 22, 2022 | Marker Therapeutics, Inc. (MRKR) | Grant/Award | 160,000 | n/a |
| May 27, 2021 | Allovir, Inc. (ALVR) | Grant/Award | 22,500 | n/a |